Login

Financial Snapshot

Revenue
TTM
$71.82M
Gross Margin
TTM
63.25%
Net Income
TTM
-$124.5M
Current Assets
2023 Q2
Current Liabilities
2023 Q2
Current Ratio
2023 Q2
224.48%
Total Assets
2023 Q2
Total Liabilities
2023 Q2
Book Value
2023 Q2
$111.3M
Cash
2023 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$66.21M

Stock Price

Loading...
Market Cap: $97.686 Million

About Bruker Cellular Analysis, Inc.

PhenomeX, Inc. is a biology company that engages in the study of cells. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm enables scientists to leverage each cell and drive the next generation of functional cell biology that will advance human health. The firm enables scientists to reveal insights into cell function and obtain a full view of the behavior of each cell. Its specific suite of proven tools and services offers unparalleled resolution and speed the insights that are key to advancing discoveries that can completely improve the prevention and treatment of disease. The Company’s platforms are used by researchers across the globe, including various global pharmaceutical companies and approximately 85% of United States cancer centers.

Industry: Laboratory Analytical Instruments Peers: Absci Corp Nautilus Biotechnology Inc Codexis Inc Quantum-Si Inc Science 37 Holdings, Inc. Personalis Inc Quanterix Corp Rapid Micro Biosystems, Inc Singular Genomics Systems, Inc. Thermo Fisher Scientific Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support